Mark C. Schneyer - EVP, CHIEF FINANCIAL OFFICER at Acadia Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Evp, Chief Financial Officer
Stock Symbol
ACAD on Nasdaq
All Insider Reports
All Insider Reports

Mark C. Schneyer - trading volume in the past year for Acadia Pharmaceuticals Inc

Holdings reported by Mark C. Schneyer for Acadia Pharmaceuticals Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 40.1K $1.01M $25.18 Aug 18, 2025 Direct
Restricted Stock Units 13.6K $78.2K $14.82 May 1, 2025 Direct Common Stock
Stock Option (Right to Buy) 111K Mar 24, 2025 Direct Common Stock

Transactions reported by Mark C. Schneyer for Acadia Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.